Bär & Karrer acted as lead legal counsel to dsm-firmenich on the completion of its additional listing on SIX Swiss Exchange, where the company's shares now trade under the ticker symbol DSFIR alongside its
Tags :dsm-firmenich
Bär & Karrer advised Dsm-firmenich, as the Swiss company active across the nutrition, health and beauty sectors entered into an agreement with private markets manager CVC to divest its Animal Nutrition & Health (ANH)
Walder Wyss advised dsm-firmenich on the sale of Pentapharm and its Brazilian sister company Pentapharm do Brasil Comércio e Exportação to Orlando Capital V. Founded in 1948 and headquartered in Aesch, Pentapharm is a
Bär & Karrer has advised DSM-Firmenich on the Swiss legal aspects of the sale of the majority of its indirect stake in Robertet, a manufacturer of flavours, fragrances, and natural extracts. The transaction closed
Baker McKenzie advised KD Pharma Group, a global producer of pharmaceutical and nutritional lipids, on the acquisition of dsm-firmenich’s marine lipids business in exchange for a minority stake in KD Pharma Group. The transaction
